1 rich Libsyn https://www.libsyn.com 90 600 In this week’s View, Dr. Eagle looks at the&amp;nbsp;DANISH&amp;nbsp;trial extended&amp;nbsp;follow-up, evaluating which patients&amp;nbsp;benefit&amp;nbsp;most from primary prevention&amp;nbsp;implantable&amp;nbsp;cardioverter&amp;nbsp;defibrillator&amp;nbsp;(ICD) implantation. He then explores the&amp;nbsp;SURMOUNT-4 study on weight reversal post&amp;nbsp;tirzepatide&amp;nbsp;withdrawal.&amp;nbsp;Finally, Dr. Eagle examines&amp;nbsp;two JACC&amp;nbsp;articles&amp;nbsp;that&amp;nbsp;cover&amp;nbsp;disease&amp;nbsp;monitoring: one tracking&amp;nbsp;the progression of&amp;nbsp;transthyretin amyloid cardiomyopathy (ATTR-CM)&amp;nbsp;and another&amp;nbsp;assessing&amp;nbsp;cardiovascular&amp;nbsp;risks in patients receiving cancer therapy.  &amp;nbsp; &amp;nbsp;Subscribe to Eagle’s Eye View&amp;nbsp;&amp;nbsp; Eagle's Eye View: Your Weekly CV Update From ACC.org http://www.acc.org <iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/39416980/height/90/theme/custom/thumbnail/yes/direction/forward/render-playlist/no/custom-color/88AA3C/" height="90" width="600" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe> https://assets.libsyn.com/secure/content/196587455